C

COMPASS Pathways Plc
D

CMPS

11.930
USD
-0.26
(-2.13%)
قبل الجلسة·12.110USD+0.180(+1.51%)
حجم التداول
62,430
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
1,609,945,388
أصول ذات صلة المقالات
المزيد

العنوان: COMPASS Pathways Plc

القطاع: Healthcare
الصناعة: Medical Care Facilities
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.